CH498113A - Hypotensive dihydropyridines - Google Patents
Hypotensive dihydropyridinesInfo
- Publication number
- CH498113A CH498113A CH169368A CH169368A CH498113A CH 498113 A CH498113 A CH 498113A CH 169368 A CH169368 A CH 169368A CH 169368 A CH169368 A CH 169368A CH 498113 A CH498113 A CH 498113A
- Authority
- CH
- Switzerland
- Prior art keywords
- alkyl
- general formula
- dihydro
- hypotensive
- dihydropyridines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
(A) Pharmaceutical prepns. contng. as active ingredient a dihydropyridine deriv. (I) R' = 1-6C alkyl R2 = COOR', COR" R3 = Ph opt. substd. by mono/di-halo, mono/di/tri-1-4C alkyl/alkoxy, CF3; benzyl styryl, furyl, thienyl R4 = H, 1-6C alkyl R',R" = 1-6C alkyl (B) Cpds. of formula (II):- As hypotensive agents. Unit doses; 25-250 mg. for oral admin. at levels of 0.5-5 mg/kg.
Description
Verfahren zur Herstellung von 1,4-Dihydro-4-(2-trifluormethylphenyl)-pyridinen
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von neuen 1 ,4-Dihydro-4-(2-tnfluormethyl- phenyl)-pyridinen der allgemeinen Formel I
EMI1.1
in der R, und R2 Alkylreste mit 1 bis 6 Kohlenstoffatomen bedeuten.
Diese neuen Verbindungen sind Arzneimittel, und sie besitzen blutdrucksenkende Wirkung. Eine bevorzugte Verbindung der allgemeinen Formel list 3,5-Dicarbäthoxy- l,4-dihydro-2,6-dimethyl-4-(2-trifluormethyl- phenyl)-pyridin, dass bei oraler Verabreichung eine besonders kräftige blutdrucksenkende Wirkung von ver hältnismässig langer Dauer zeigt.
Die Erfindung betrifft ein Verfahren zur Herstellung der Verbindungen der allgemeinen Formel I, das dadurch gekennzeichnet ist, dass man etwa 1 Moläquivalent o- -Trifluormethylbenzaldehyd mit etwa 2 Moläquivalenten eines Acylessigsäureesters der allgemeinen Formel II
EMI1.2
in der R1 und R.5 die obige Bedeutung haben, sowie Ammoniak im Überschuss bei erhöhter Temperatur kondensiert.
Vorzugsweise wird das erfindungsgemässe Verfahren in einem Lösungsmittel, z.B. einem niederen aliphatischen Alkohol oder Dioxan, unter Rückflusskochen des Reaktionsgemisches durchgeführt. Die Reaktionszeit beträgt vorzugsweise 1 bis 4 Stunden.
Das erfindungsgemässe Verfahren verläuft schematisch nach folgender Reaktionsgleichung
EMI1.3
Obgleich die Formel der erfindungsgemässen 2-Trifluormethyl-phenyl-dihydropyridine so gezeichnet ist, als hätten sie die 1,4-Dihydropyridinstruktur, ist die Lage der Doppelbindungen nicht mit Sicherheit in jedem Fall bekannt. Einige dieser Verbindungen können die folgende 1,2-Dihydrostruktur haben:
EMI1.4
Das Beispiel erläutert die Erfindung.
Beispiel
12 g des Diäthylacetals von o-Trifluormethylbenzaldehyd werden mit 50 ml 6n Salzsäure unter Stickstoff versetzt und 3 Stunden unter Rückfluss gekocht. Das Reaktionsgemisch wird abgekühlt und die ölige von der wässrigen Schicht getrennt. Die wässrige Schicht wird mit etwa 25 ml Methylenchlorid gewaschen. Der Extrakt wird mit dem öl vereinigt und dazu werden 12,6 g Acetessigsäureäthylester, dann 25 ml Äthanol und 5,0 ml konzentrierter wässriger Ammoniak gegeben. Die erhaltene Mischung wird 19 Stunden unter Rückfluss gekocht, dann abgekühlt und auf etwa 500 ml Eis-Wasser gegossen. Nach Filtrieren und Umkristallisieren aus Isopropyläther erhält man 3,5-Dicarbäthoxy-1,4-dihydro-2,6-di- methyl-4-(2-trifluormethylphenyl)-pyridin vom Fp. 140142,50C.
Process for the preparation of 1,4-dihydro-4- (2-trifluoromethylphenyl) pyridines
The present invention relates to a process for the preparation of new 1,4-dihydro-4- (2-fluoromethyl-phenyl) -pyridines of the general formula I.
EMI1.1
in which R, and R2 denote alkyl radicals having 1 to 6 carbon atoms.
These new compounds are medicines and they have antihypertensive effects. A preferred compound of the general formula is 3,5-dicarbethoxy- 1,4-dihydro-2,6-dimethyl-4- (2-trifluoromethyl-phenyl) -pyridine that, when administered orally, has a particularly powerful antihypertensive effect that is relatively long Duration shows.
The invention relates to a process for the preparation of the compounds of the general formula I, which is characterized in that about 1 molar equivalent of o- trifluoromethylbenzaldehyde is mixed with about 2 molar equivalents of an acyl acetic acid ester of the general formula II
EMI1.2
in which R1 and R.5 have the above meaning, as well as excess ammonia condensed at elevated temperature.
Preferably the process according to the invention is carried out in a solvent, e.g. a lower aliphatic alcohol or dioxane, carried out by refluxing the reaction mixture. The reaction time is preferably 1 to 4 hours.
The process according to the invention runs schematically according to the following reaction equation
EMI1.3
Although the formula of the 2-trifluoromethyl-phenyl-dihydropyridines according to the invention is drawn as if they had the 1,4-dihydropyridine structure, the position of the double bonds is not known with certainty in every case. Some of these compounds can have the following 1,2-dihydro structure:
EMI1.4
The example illustrates the invention.
example
12 g of the diethylacetal of o-trifluoromethylbenzaldehyde are mixed with 50 ml of 6N hydrochloric acid under nitrogen and refluxed for 3 hours. The reaction mixture is cooled and the oily layer is separated from the aqueous layer. The aqueous layer is washed with about 25 ml of methylene chloride. The extract is combined with the oil and 12.6 g of ethyl acetoacetate, then 25 ml of ethanol and 5.0 ml of concentrated aqueous ammonia are added. The mixture obtained is refluxed for 19 hours, then cooled and poured onto about 500 ml of ice-water. After filtration and recrystallization from isopropyl ether, 3,5-dicarbethoxy-1,4-dihydro-2,6-dimethyl-4- (2-trifluoromethylphenyl) pyridine of melting point 140142.50C is obtained.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61439367A | 1967-02-07 | 1967-02-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH498113A true CH498113A (en) | 1970-10-31 |
Family
ID=24461057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH169368A CH498113A (en) | 1967-02-07 | 1968-02-06 | Hypotensive dihydropyridines |
Country Status (13)
Country | Link |
---|---|
US (1) | US3441648A (en) |
BE (1) | BE710391A (en) |
CH (1) | CH498113A (en) |
DE (1) | DE1695826C3 (en) |
DK (1) | DK131819C (en) |
ES (1) | ES350204A1 (en) |
FI (1) | FI49299C (en) |
FR (2) | FR7046M (en) |
GB (1) | GB1167447A (en) |
IE (1) | IE31932B1 (en) |
IL (1) | IL29354A (en) |
NL (1) | NL156135B (en) |
SE (1) | SE337024B (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1923990C3 (en) * | 1969-05-10 | 1978-11-23 | Bayer Ag | Process for the preparation of N-substituted M-dihydropyridine-S.S-dicarboxylic acid esters |
DE1963186C3 (en) * | 1969-12-17 | 1979-02-15 | Bayer Ag, 5090 Leverkusen | Sulfur-containing 1,4-dihydropyridine-33-dicarboxylic acid esters |
DE1963188A1 (en) * | 1969-12-17 | 1971-06-24 | Bayer Ag | New cyanophenyl-1,4-dihydropyridine derivatives |
US3862161A (en) * | 1970-01-24 | 1975-01-21 | Bayer Ag | 4-pyridyl substituted 1,4-dihydropyridines |
DE2005116C3 (en) * | 1970-02-05 | 1980-02-14 | Bayer Ag, 5090 Leverkusen | Symmetrical 1,4-dihydropyridine-3,5-dicarboxylic acid esters |
GB1430961A (en) * | 1972-01-22 | 1976-04-07 | Yamanouchi Pharma Co Ltd | 1-substituted-1,4-dihyddrypyridine derivatives |
US3971790A (en) * | 1972-03-06 | 1976-07-27 | Bayer Aktiengesellschaft | 2-Amino-1,4-dihydropyridine derivatives |
US3971791A (en) * | 1972-03-06 | 1976-07-27 | Bayer Aktiengesellschaft | 2-Amino-1,4-dihydropyridine derivatives |
US3922278A (en) * | 1972-06-12 | 1975-11-25 | Sterling Drug Inc | 4-(3-Nitrophenyl)-3,5-pyridinedicarboxylic acid |
US4136187A (en) * | 1972-08-12 | 1979-01-23 | Bayer Aktiengesellschaft | Antihypertensive 2-amino-4,5-dihydropyridine derivatives |
DE2239815C2 (en) * | 1972-08-12 | 1983-02-10 | Bayer Ag, 5090 Leverkusen | 2-Alkylamino-dihydropyridines, processes for their preparation and pharmaceuticals containing them |
SU706410A1 (en) * | 1978-01-11 | 1979-12-30 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвийской Сср | 2,6-dimethyl-3,5-dicarbomethoxy-4-(o-difluoromethoxyphenyl)-1,4-dihydropyridine possessing expressed hypotensive activity and exhibiting action on vegetative nervous system functions |
SE429652B (en) * | 1978-06-30 | 1983-09-19 | Haessle Ab | 2,6-dimethyl-4- (2,3-dichlorophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3-methyl 5-ethyl ester |
US4285955A (en) * | 1978-10-31 | 1981-08-25 | Bayer Aktiengesellschaft | 1,4-Dihydropyridinecarboxylic acids |
US4365063A (en) * | 1981-08-31 | 1982-12-21 | American Home Products Corporation | Antihypertensive agents |
US4321384A (en) * | 1981-02-27 | 1982-03-23 | American Home Products Corporation | Antihypertensive agents |
US4435574A (en) * | 1981-07-20 | 1984-03-06 | Kastron Valeria V | 2,6-Dimethyl-3,5-dicarbomethoxy-4-(ortho-di-fluoromethylthiophenyl)-1,4-dihydropyridine |
US4677101A (en) * | 1983-09-26 | 1987-06-30 | Merck & Co., Inc. | Substituted dihydroazepines useful as calcium channel blockers |
IE57810B1 (en) * | 1984-03-27 | 1993-04-21 | Delagrange Lab | 1,4-dihydropyridine derivatives,their preparation and their use |
US4652573A (en) * | 1985-03-14 | 1987-03-24 | Nelson Research & Development Co. | Calcium antagonist N-hetero ester 1,4-dihydropyridines |
US4771057A (en) * | 1986-02-03 | 1988-09-13 | University Of Alberta | Reduced pyridyl derivatives with cardiovascular regulating properties |
US4849436A (en) * | 1986-03-11 | 1989-07-18 | Nelson Research & Development Co. | 1,4-dihydropyridines |
ATE61588T1 (en) * | 1987-08-03 | 1991-03-15 | Delagrange Lab | 1,4-DIHYDROPYRIDINES, PROCESSES FOR THEIR PRODUCTION AND USE AS MEDICINAL PRODUCTS. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3221017A (en) * | 1964-04-07 | 1965-11-30 | Aldrich Chem Co Inc | Aralkoxyamides of 4-phenyl-1,2,5,6-tetrahydropyridino alkanoic acids and intermediates thereof |
US3325505A (en) * | 1965-02-24 | 1967-06-13 | Smith Kline French Lab | 4-cycloalkyl(or cycloalkenyl)-dihydropyridines |
-
1967
- 1967-02-07 US US614393A patent/US3441648A/en not_active Expired - Lifetime
-
1968
- 1968-01-17 DK DK16968*#A patent/DK131819C/en active
- 1968-01-21 IL IL29354A patent/IL29354A/en unknown
- 1968-01-25 GB GB4049/68A patent/GB1167447A/en not_active Expired
- 1968-01-31 FI FI680251A patent/FI49299C/en active
- 1968-01-31 IE IE121/68A patent/IE31932B1/en unknown
- 1968-02-01 DE DE1695826A patent/DE1695826C3/en not_active Expired
- 1968-02-02 SE SE01402/68A patent/SE337024B/xx unknown
- 1968-02-05 FR FR138648A patent/FR7046M/fr not_active Expired
- 1968-02-05 FR FR1574702D patent/FR1574702A/fr not_active Expired
- 1968-02-06 BE BE710391D patent/BE710391A/xx not_active IP Right Cessation
- 1968-02-06 ES ES350204A patent/ES350204A1/en not_active Expired
- 1968-02-06 CH CH169368A patent/CH498113A/en not_active IP Right Cessation
- 1968-02-07 NL NL6801710.A patent/NL156135B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE337024B (en) | 1971-07-26 |
DE1695826C3 (en) | 1978-03-23 |
IE31932L (en) | 1968-08-07 |
FR1574702A (en) | 1969-07-18 |
DE1695826B2 (en) | 1977-07-14 |
NL6801710A (en) | 1968-08-08 |
DK131819C (en) | 1976-02-09 |
FR7046M (en) | 1969-06-16 |
FI49299C (en) | 1975-05-12 |
IE31932B1 (en) | 1973-02-21 |
FI49299B (en) | 1975-01-31 |
DE1695826A1 (en) | 1971-05-13 |
GB1167447A (en) | 1969-10-15 |
ES350204A1 (en) | 1969-04-16 |
US3441648A (en) | 1969-04-29 |
DK131819B (en) | 1975-09-08 |
BE710391A (en) | 1968-08-06 |
NL156135B (en) | 1978-03-15 |
IL29354A (en) | 1971-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH498113A (en) | Hypotensive dihydropyridines | |
DE1923990C3 (en) | Process for the preparation of N-substituted M-dihydropyridine-S.S-dicarboxylic acid esters | |
US4656181A (en) | Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same | |
EP0176956B1 (en) | Diaryl derivatives | |
DD154014A5 (en) | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINES | |
DE2218644A1 (en) | BASIC ESTERS OF 1,4-DIHYDROPYRIDINES, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT | |
DE2658183A1 (en) | 2-POSITION SUBSTITUTED 1,4-DIHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS A MEDICINAL PRODUCT | |
DE2013431C3 (en) | 4-Azidophenyl-1,4-dihydropyridine-3,5-dicarboxylic acid ester | |
DE1670824B2 (en) | 1,4-DIHYDROPYRIDINE-3,5-DICARBONIC ACID ALKYLESTER | |
DE2005116A1 (en) | New 1,4 dihydropyridine indenvates | |
CH664757A5 (en) | PHARMACEUTICAL USEFUL DIHYDROPYRIDINYLCARBONIC ACID AND ESTER. | |
DE1963186C3 (en) | Sulfur-containing 1,4-dihydropyridine-33-dicarboxylic acid esters | |
CH642353A5 (en) | 2-METHYL-DIHYDROPYRIDINE COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENT CONTAINING IT. | |
DE2335466A1 (en) | ALCOXY ALKYL-1,4-DIHYDROPYRIDINE, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT | |
CH647519A5 (en) | HIGH PRESSURE REDUCING AMINES. | |
DE3222367A1 (en) | Use of 1,4-dihydropyridines in antiarteriosclerotics and preparation thereof | |
DE2406198C2 (en) | Process for the preparation of new 2-amino-6-dialkylamino-dihydropyridines | |
EP0342182A1 (en) | Derivatives of 5-aminomethyl-2-furan methanol, their preparation and use | |
DE2000030B2 (en) | 3 alkoxy and 3 phenoxy 2 (diphenyl hydroxy) methyl propylamine and medicinal products containing them | |
JP2640245B2 (en) | 1,4-dihydropyridine derivative | |
DE2456098B2 (en) | Xanthene and thioxanthene derivatives, processes for their preparation and pharmaceuticals containing these compounds | |
EP0225574B1 (en) | Novel 1,4-dihydropyridines containing fluorine, process for their preparation and their use as medicaments | |
US4435574A (en) | 2,6-Dimethyl-3,5-dicarbomethoxy-4-(ortho-di-fluoromethylthiophenyl)-1,4-dihydropyridine | |
DE3816361A1 (en) | (-)-Menthyl 1,4-dihydropyridinedicarboxylates | |
EP0240828A1 (en) | Optically active 1,4-dihydropyridine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |